Daiichi Sankyo isn't taking chances on Ranbaxy Laboratories' ability to keep turning out FDA-compliant drugs. The Japanese drugmaker, which owns the controlling interest in the Indian company, has dispatched two executives to the Punjab facility to keep a close eye on operations there, The Economic Times says. Report
Read more: Daiichi sends in posse to keep Ranbaxy plant in line - FiercePharma http://www.fiercepharma.com/story/daiichi-sends-posse-keep-ranbaxy-plant-line/2012-01-17#ixzz1ucnBdeyE
Subscribe: http://www.fiercepharma.com/signup?sourceform=Viral-Tynt-FiercePharma-FiercePharma
No comments:
Post a Comment
Please feel free to contact or comment the article